Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.
Saved in:
| Title: | Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses. |
|---|---|
| Authors: | Jossi SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Arcuri M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; GSK Vaccines Institute for Global Health SRL, Siena, Italy., Alshayea A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Persaud RR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Marcial-Juárez E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Palmieri E; GSK Vaccines Institute for Global Health SRL, Siena, Italy., Di Benedetto R; GSK Vaccines Institute for Global Health SRL, Siena, Italy., Pérez-Toledo M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Pillaye J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Channell WM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Schager AE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Lamerton RE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Cook CN; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Goodall M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Haneda T; Laboratory of Microbiology, School of Pharmacy, Kitasato University, Tokyo, Japan., Bäumler AJ; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA, United States., Jackson-Jones LH; Division of Biomedical and Life Sciences, Lancaster University, Lancaster, United Kingdom., Toellner KM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., MacLennan CA; Bill & Melinda Gates Foundation, London, United Kingdom.; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Henderson IR; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia., Micoli F; GSK Vaccines Institute for Global Health SRL, Siena, Italy., Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Mar 23; Vol. 14, pp. 1139329. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37033932 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jossi+SE%22">Jossi SE</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Arcuri+M%22">Arcuri M</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; GSK Vaccines Institute for Global Health SRL, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Alshayea+A%22">Alshayea A</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Persaud+RR%22">Persaud RR</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Marcial-Juárez+E%22">Marcial-Juárez E</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Palmieri+E%22">Palmieri E</searchLink>; GSK Vaccines Institute for Global Health SRL, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Benedetto+R%22">Di Benedetto R</searchLink>; GSK Vaccines Institute for Global Health SRL, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Pérez-Toledo+M%22">Pérez-Toledo M</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pillaye+J%22">Pillaye J</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Channell+WM%22">Channell WM</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schager+AE%22">Schager AE</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lamerton+RE%22">Lamerton RE</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cook+CN%22">Cook CN</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goodall+M%22">Goodall M</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Haneda+T%22">Haneda T</searchLink>; Laboratory of Microbiology, School of Pharmacy, Kitasato University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Bäumler+AJ%22">Bäumler AJ</searchLink>; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA, United States.<br /><searchLink fieldCode="AU" term="%22Jackson-Jones+LH%22">Jackson-Jones LH</searchLink>; Division of Biomedical and Life Sciences, Lancaster University, Lancaster, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Toellner+KM%22">Toellner KM</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22MacLennan+CA%22">MacLennan CA</searchLink>; Bill & Melinda Gates Foundation, London, United Kingdom.; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Henderson+IR%22">Henderson IR</searchLink>; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Micoli+F%22">Micoli F</searchLink>; GSK Vaccines Institute for Global Health SRL, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Cunningham+AF%22">Cunningham AF</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Mar 23; Vol. 14, pp. 1139329. <i>Date of Electronic Publication: </i>2023 Mar 23 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37033932 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1139329 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1139329 Titles: – TitleFull: Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jossi SE – PersonEntity: Name: NameFull: Arcuri M – PersonEntity: Name: NameFull: Alshayea A – PersonEntity: Name: NameFull: Persaud RR – PersonEntity: Name: NameFull: Marcial-Juárez E – PersonEntity: Name: NameFull: Palmieri E – PersonEntity: Name: NameFull: Di Benedetto R – PersonEntity: Name: NameFull: Pérez-Toledo M – PersonEntity: Name: NameFull: Pillaye J – PersonEntity: Name: NameFull: Channell WM – PersonEntity: Name: NameFull: Schager AE – PersonEntity: Name: NameFull: Lamerton RE – PersonEntity: Name: NameFull: Cook CN – PersonEntity: Name: NameFull: Goodall M – PersonEntity: Name: NameFull: Haneda T – PersonEntity: Name: NameFull: Bäumler AJ – PersonEntity: Name: NameFull: Jackson-Jones LH – PersonEntity: Name: NameFull: Toellner KM – PersonEntity: Name: NameFull: MacLennan CA – PersonEntity: Name: NameFull: Henderson IR – PersonEntity: Name: NameFull: Micoli F – PersonEntity: Name: NameFull: Cunningham AF IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 03 Text: 2023 Mar 23 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
